Anil B. Jindal

1.8k total citations
71 papers, 1.3k citations indexed

About

Anil B. Jindal is a scholar working on Pharmaceutical Science, Molecular Biology and Strategy and Management. According to data from OpenAlex, Anil B. Jindal has authored 71 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmaceutical Science, 13 papers in Molecular Biology and 13 papers in Strategy and Management. Recurrent topics in Anil B. Jindal's work include Advanced Drug Delivery Systems (16 papers), Sustainable Supply Chain Management (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Anil B. Jindal is often cited by papers focused on Advanced Drug Delivery Systems (16 papers), Sustainable Supply Chain Management (10 papers) and Nanoparticle-Based Drug Delivery (9 papers). Anil B. Jindal collaborates with scholars based in India, United States and Germany. Anil B. Jindal's co-authors include Kuldip Singh Sangwan, Padma V. Devarajan, Derajram Benival, Dhwani Rana, Sagar Salave, Satyendra Kumar Sharma, Abdul Samad, Atish T. Paul, Rajiv V. Gaikwad and Rajesh R. Patil and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Anil B. Jindal

68 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anil B. Jindal India 19 319 289 236 215 162 71 1.3k
Pei‐Ling Lee Taiwan 12 134 0.4× 184 0.6× 153 0.6× 94 0.4× 171 1.1× 28 912
Zhuo Dai China 12 160 0.5× 58 0.2× 323 1.4× 272 1.3× 121 0.7× 27 879
Abhishek Kumar Sharma India 12 75 0.2× 63 0.2× 97 0.4× 110 0.5× 83 0.5× 26 686
Clara Fernandes India 9 130 0.4× 49 0.2× 99 0.4× 114 0.5× 59 0.4× 10 455
Rajender Kumar India 30 64 0.2× 74 0.3× 700 3.0× 195 0.9× 36 0.2× 237 2.9k
Yun‐Chu Chen Taiwan 16 96 0.3× 38 0.1× 258 1.1× 54 0.3× 107 0.7× 41 946
Hirokazu Sugiyama Japan 20 173 0.5× 62 0.2× 293 1.2× 22 0.1× 15 0.1× 114 1.3k
Pratibha Sharma India 21 115 0.4× 27 0.1× 167 0.7× 178 0.8× 20 0.1× 65 1.6k
Sau L. Lee United States 19 32 0.1× 395 1.4× 513 2.2× 268 1.2× 44 0.3× 28 2.0k
Zhengwei Huang China 24 31 0.1× 469 1.6× 406 1.7× 318 1.5× 69 0.4× 116 1.7k

Countries citing papers authored by Anil B. Jindal

Since Specialization
Citations

This map shows the geographic impact of Anil B. Jindal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil B. Jindal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil B. Jindal more than expected).

Fields of papers citing papers by Anil B. Jindal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil B. Jindal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil B. Jindal. The network helps show where Anil B. Jindal may publish in the future.

Co-authorship network of co-authors of Anil B. Jindal

This figure shows the co-authorship network connecting the top 25 collaborators of Anil B. Jindal. A scholar is included among the top collaborators of Anil B. Jindal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil B. Jindal. Anil B. Jindal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jindal, Anil B., et al.. (2025). Current status of Liraglutide delivery systems for the management of type 2 diabetes mellitus. Drug Delivery and Translational Research. 15(12). 4479–4500.
3.
Jindal, Anil B., et al.. (2024). Recent innovations in topical delivery for management of rheumatoid arthritis: A focus on combination drug delivery. Drug Discovery Today. 29(8). 104071–104071. 8 indexed citations
4.
Benival, Derajram, et al.. (2024). Formulation Strategies to Overcome Amphotericin B Induced Toxicity. Molecular Pharmaceutics. 21(11). 5392–5412. 11 indexed citations
5.
Jindal, Anil B., et al.. (2024). An Insight Into Risk Assessment and Reformulation of Drug Products Manufactured Using Benzene Grade Carbomer: A Regulatory Perspective. AAPS PharmSciTech. 25(6). 166–166. 1 indexed citations
6.
Rana, Dhwani, et al.. (2024). Investigating a novel therapeutic composition for dry eye syndrome management: In vitro and in vivo studies. International Journal of Pharmaceutics. 666. 124783–124783. 2 indexed citations
7.
Salave, Sagar, et al.. (2023). Intranasal transmucosal drug delivery: An alternative approach to the parenteral route for medical emergencies. Journal of Drug Delivery Science and Technology. 83. 104421–104421. 12 indexed citations
8.
Jindal, Anil B., et al.. (2023). Topical Nanotherapeutics for Treating MRSA-Associated Skin and Soft Tissue Infection (SSTIs). AAPS PharmSciTech. 24(5). 108–108. 11 indexed citations
9.
Patravale, Vandana, Abhijit A. Date, & Anil B. Jindal. (2023). Nanomedicines for the Prevention and Treatment of Infectious Diseases. 3 indexed citations
10.
Paul, Atish T., et al.. (2023). Preclinical evaluation of quinapyramine sulphate-loaded lipidic nanocarriers for trypanocidal effect against Trypanosoma evansi. Journal of Drug Delivery Science and Technology. 81. 104215–104215. 4 indexed citations
11.
Sahoo, Prabhat Kumar, et al.. (2023). Freeze-drying revolution: unleashing the potential of lyophilization in advancing drug delivery systems. Drug Delivery and Translational Research. 14(5). 1111–1153. 18 indexed citations
12.
Jindal, Anil B., et al.. (2023). Long-acting parenteral drug delivery systems for the treatment of chronic diseases. Advanced Drug Delivery Reviews. 198. 114862–114862. 56 indexed citations
13.
Paul, Atish T., et al.. (2023). Long-term antitrypanosomal effect of quinapyramine sulphate-loaded oil-based nanosuspension in T. evansi-infected mouse model. Drug Delivery and Translational Research. 14(2). 542–554. 1 indexed citations
14.
Jindal, Anil B., et al.. (2022). Current status of dolutegravir delivery systems for the treatment of HIV-1 infection. Journal of Drug Delivery Science and Technology. 76. 103802–103802. 6 indexed citations
15.
Kaur, Sukhbir, et al.. (2022). Evaluation of Pharmacokinetics, Biodistribution, and Antimalarial Efficacy of Artemether-Loaded Polymeric Nanorods. Molecular Pharmaceutics. 20(1). 118–127. 5 indexed citations
17.
Jindal, Anil B., et al.. (2017). Development of efavirenz loaded solid lipid nanoparticles: Risk assessment, quality-by-design (QbD) based optimisation and physicochemical characterisation. Journal of Drug Delivery Science and Technology. 39. 180–191. 64 indexed citations
18.
Jindal, Anil B., et al.. (2013). REVIEW ON CURRENT TRENDS AND ADVANCEMENT IN DRUGS TRENDS AND DRUG TARGETS FOR TUBERCULOSIS THERAPY.. International Journal of Pharma and Bio Sciences. 1 indexed citations
19.
Jindal, Anil B.. (2012). PHYSICOCHEMICAL AND PHYTOCHEMICAL EVALUATION OF PISTACIA INTEGERRIMA STEW EX BRAND. 4(7). 24–27. 1 indexed citations
20.
Jindal, Anil B., et al.. (2010). Synthesis of thiolated alginate and evaluation of mucoadhesiveness, cytotoxicity and release retardant properties. Indian Journal of Pharmaceutical Sciences. 72(6). 766–766. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026